Partner Headlines - LLY

  1. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD
  2. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus
  3. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus
  4. 8 Dividend Stocks With The Right Qualities

    GuruFocus
  5. MannKind Looks Good For Long Term Investors

    GuruFocus
  6. Citigroup Upgrades Eli Lilly To Buy

    Benzinga
  7. Novartis EPS beats the Street

    IBD
  8. Eli Lilly

    IBD
  9. US Stock Futures Down Ahead Of Earnings, Economic Data

    Benzinga
  10. Eli Lilly Tops Q1 Views

    Benzinga
  11. Eli Lilly Partner Deciphera Pharma Announces Data Highlighting ...

    Benzinga
  12. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD
  13. 5 'Key Pipeline Catalysts' To Watch At Eli Lilly

    Benzinga
  14. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD
  15. IPO Alert: Biotech Investors Should Watch Advanced Accelerator's ...

    Benzinga
  16. UBS: Eli Lilly's 'Outlook Continuing To Improve'

    Benzinga
  17. Eli Lilly CEO Explains The Reasons Behind Not Changing 2015 Guidance ...

    Benzinga
  18. Viekira Pak View Falls Short

    IBD
  19. AbbVie Beats, But Stock Falls; Lilly Cuts Guidance

    IBD
  20. UPDATE: Eli Lilly Posts Upbeat Q4 Profit, Sales Decline

    Benzinga
  21. Earnings Scheduled For January 30, 2015

    Benzinga
  22. 10 Must Watch Stocks for Today

    Benzinga
  23. Box Ready To Unwrap IPO In Hot Online Storage Field

    IBD
  24. Feeling Good With This Med Company

    GuruFocus
  25. Eli Lilly

    IBD
  26. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga
  27. 10 Biotech Stories You Might've Missed This Week

    Benzinga
  28. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  29. Exclusive: JPMorgan Chase CEO Jamie Dimon Talks Cancer Recovery, ...

    FoxBusiness
  30. Eil Lilly CEO Talks New Product Launches, Pricing Pressure From ...

    Benzinga
  31. FDA Issues Import Block On Eli Lilly's Cialis

    Benzinga
  32. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  33. Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

    Benzinga
  34. Benzinga's Top Upgrades

    Benzinga
  35. Jefferies Upgrades Eli Lilly To Buy

    Benzinga
  36. UPDATE: Deutsche Bank Downgrades Eli Lilly On Positive Outlook, ...

    Benzinga
  37. Eli Lilly

    IBD
  38. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  39. Eli Lilly Moves Higher Following FY 2014 & 2015 Outlook

    Benzinga
  40. Benzinga's Top #PreMarket Losers

    Benzinga
  41. Fast Money Halftime Report Final Trade From January 6

    Benzinga
  42. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga
  43. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  44. 7 Stocks You Should Be Watching Today

    Benzinga
  45. Eli Lilly

    IBD
  46. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  47. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  48. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  49. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  50. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  51. Screening Pharma Stocks Amid Turnaround

    YCharts
  52. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  53. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  54. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  55. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  56. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  57. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  58. Earnings Scheduled For October 23, 2014

    Benzinga
  59. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  60. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  61. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  62. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  63. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  64. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  65. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  66. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  67. Meet 5 Top International Stocks Not Based In China

    IBD
  68. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  69. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  70. Drug giants target Alzheimer's

    IBD
  71. What Is A High Risk Market?

    Benzinga
  72. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  73. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  74. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  75. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  76. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  77. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  78. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  79. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  80. Thursday Morning Earnings Reports

    Benzinga
  81. Earnings Scheduled For July 24, 2014

    Benzinga
  82. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  83. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  84. Benzinga's Top #PreMarket Gainers

    Benzinga
  85. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  86. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  87. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  88. Benzinga's Top Upgrades

    Benzinga
  89. Eli Lilly is on the Right Track

    GuruFocus
  90. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  91. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  92. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  93. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  94. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  95. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  96. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  97. Eli Lilly insulin trial succeeds

    IBD
  98. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  99. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  100. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
Trading Center